Key result
A pharmacist-led pharmaceutical care programme significantly improved exercise tolerance (1607.2 vs 1403.3 m.month, P<0.05) and quality of life compared to traditional services in heart failure.
Why the study?
Does a pharmacist-led pharmaceutical care programme improve clinical and humanistic outcomes in patients with heart failure?
Population
208 patients with heart failure recruited from general medical wards and cardiology/medical outpatient…
Comparison
Pharmacist-led pharmaceutical care programme… vs Traditional services.
Design
RCT, Randomly assigned to one of two groups
Follow-up
12 months
Authors
Loading...
Supports integrating pharmacist-led care into heart failure management; extends RCT evidence for multidisciplinary programs.
RCT (n=208)
randomly assigned
No
Does a pharmacist-led pharmaceutical care programme improve clinical and humanistic outcomes in patients with heart failure?
Absolute Event Rate: 1607.2% vs 1403.3%
p-value: p=< 0.05
A pharmacist-led pharmaceutical care program significantly improves exercise tolerance, quality of life, and medication adherence in patients with heart failure.
Sadik et al. (2005) conducted an RCT in heart failure (n=208). pharmacist-led pharmaceutical care programme vs. traditional services was evaluated on exercise tolerance (2-min walk test AUC, m.month) (p=< 0.05). A pharmacist-led pharmaceutical care programme significantly improved exercise tolerance (1607.2 vs 1403.3 m.month, P<0.05) and quality of life compared to traditional services in heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: